Registry of gastric cancer treatment evaluation (REGATE): I baseline disease characteristics

Grants

Funding Acknowledgements

The REGATE study was sponsored by Sanofi. Editorial assistance was provided by Neil Anderson, PhD, of Adelphi Communications Ltd. Editorial support was funded by Sanofi. The authors were fully responsible for all content and editorial decisions and did not receive financial support or compensation related to the development of the manuscript. Y-JB has conducted research sponsored by AstraZeneca, GlaxoSmithKline, Green Cross, Hanmi, Merck, Novartis, Pfizer, Roche and Sanofi; has attended advisory/consultancy meetings for AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Green Cross, Hanmi, Merck, Novartis, Otsuka, Pfizer, Roche and Sanofi; and has received honoraria from AstraZeneca, GlaxoSmithKline, Novartis, Pfizer and Roche. JZ has conducted research sponsored by Sanofi.